MORRISTOWN, N.J.--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced today that Douglas Drysdale, Chairman, President and Chief Executive Officer and Sanjay Patel, Chief Financial Officer, are scheduled to present at the Annual Piper Jaffray Healthcare Conference in New York, NY on December 2, 2014.
|Event:||26th Annual Piper Jaffray Healthcare Conference|
Tuesday, December 2, 2014
|Time:||10:30-11:30 AM EST|
A live webcast of the presentation will be available on the Pernix Therapeutics website, www.pernixtx.com, under the investor relations tab. A replay of the webcast will be available for 30 days after the date of presentation.
About Pernix Therapeutics
Pernix Therapeutics is a specialty pharmaceutical business with a focus on acquiring, developing and commercializing prescription drugs primarily for the U.S. market. The Company targets underserved therapeutic areas such as CNS, including neurology and psychiatry, and has an interest in expanding into additional specialty segments. The Company promotes its branded products to physicians through its Pernix sales force, uses contracted sales organizations to market its non-core, cough and cold products, and markets its generic portfolio through its wholly owned subsidiaries, Macoven Pharmaceuticals, LLC and Cypress Pharmaceutical, Inc.
To learn more about Pernix Therapeutics, visit www.pernixtx.com.